FDA Approves LENALIDOMIDE — Zydus Pharmaceuticals USA Inc.
Zydus Pharmaceuticals USA Inc. announced on Tuesday the FDA approval of a generic version of global immunomodulatory drug manufacturer Johnson & Johnson's oral drug Lenalidomide, a strong signal of intensified price competition for the hematologic oncology franchise following the upcoming expiration of blockbuster patents.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day